Nonbinding site-directed mutants of transferrin binding protein B exhibit enhanced immunogenicity and protective capabilities.
about
Outer membrane vesicles as platform vaccine technologyProtein Crystallography in Vaccine Research and DevelopmentImpact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae.Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.Summary and Recommendations from the National Institute of Allergy and Infectious Diseases (NIAID) Workshop "Gonorrhea Vaccines: the Way Forward".Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.Identification of a Large Family of Slam-Dependent Surface Lipoproteins in Gram-Negative Bacteria.The role of structural proteomics in vaccine development: recent advances and future prospects.Iron acquisition through the bacterial transferrin receptor.Evaluation of recombinant protein superoxide dismutase of Haemophilus parasuis strain SH0165 as vaccine candidate in a mouse model.New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis.The amino acid selected for generating mutant TbpB antigens defective in binding transferrin can compromise the in vivo protective capacity.Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigensPlant-Based Vaccine for Livestock: Key Points to Unleash Platform Translation in Developing Countries
P2860
Q26766539-B50FCA24-276D-4BE1-8EAE-E1560EA0688DQ28087528-B7074B44-D118-4EB6-86A8-9213A5B30A95Q35922195-1BEA12A3-AB2B-4FA6-AB1F-FA1A94421880Q36137942-E782B3D0-CE75-46A2-8F37-10D820B1E274Q36513433-6D6AA435-6D52-4FCC-993F-FBE11F711DCFQ37163672-059F9879-84DC-4CF8-825D-38DD3B3F9B61Q37277250-7339B139-8AFA-46F4-920B-D3955C570C64Q38670395-95EEDBBD-C2E1-40C8-B48B-5234A5238A1BQ38682335-E9DB295D-1911-4A8F-8CC6-EA2EFC0D1AD0Q38748417-8DD3C222-621C-40D3-BB5B-078C758387A9Q38759870-9CC60C0D-F0CA-4CF4-9DC1-076A2B462925Q40067181-DAF5856A-BBC9-4172-B133-37A2C03F1F8FQ54216686-7EB3EBDF-2D83-42C0-9389-E9BA33CBB632Q58605756-12105ABE-4CDD-4D0D-AE26-CB48CF2E4BD8Q59257689-74429CD6-C5F6-4AD8-9591-D27AE619CE09
P2860
Nonbinding site-directed mutants of transferrin binding protein B exhibit enhanced immunogenicity and protective capabilities.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Nonbinding site-directed mutan ...... y and protective capabilities.
@en
type
label
Nonbinding site-directed mutan ...... y and protective capabilities.
@en
prefLabel
Nonbinding site-directed mutan ...... y and protective capabilities.
@en
P2093
P2860
P50
P356
P1476
Nonbinding site-directed mutan ...... ty and protective capabilities
@en
P2093
Anthony B Schryvers
Charles Calmettes
Dave Curran
Estela Costa
Jamie Fegan
Rong-Hua Yu
Trevor F Moraes
P2860
P304
P356
10.1128/IAI.02572-14
P407
P577
2014-12-29T00:00:00Z